Principia Biopharma Stock Price, News & Analysis
Company Description
Principia Biopharma (NASDAQ: PRNB) is a publicly traded pharmaceuticals: major company in the Health Technology sector.
PRNB stock has gained 226.5% over the past year.
This page provides a comprehensive overview of PRNB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Principia Biopharma (PRNB) stock. Over the past 12 months, the stock has gained 226.5%.
Latest News
Principia Biopharma has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include clinical trial, conferences, earnings. View all PRNB news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
PRNB Company Profile & Sector Positioning
Principia Biopharma (PRNB) operates in the Pharmaceuticals: Major industry within the broader Health Technology sector and is listed on the NASDAQ.